Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SANUWAVE Health (SNWV) Retained Earnings (2016 - 2026)

SANUWAVE Health has reported Retained Earnings over the past 17 years, most recently at -$244.1 million for Q1 2026.

  • Quarterly Retained Earnings rose 6.33% to -$244.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$244.1 million through Mar 2026, up 6.33% year-over-year, with the annual reading at $10000.0 for FY2025, 100.0% up from the prior year.
  • Retained Earnings was -$244.1 million for Q1 2026 at SANUWAVE Health, down from $10000.0 in the prior quarter.
  • Over five years, Retained Earnings peaked at $10000.0 in Q2 2024 and troughed at -$260.6 million in Q1 2025.
  • The 5-year median for Retained Earnings is -$211.0 million (2023), against an average of -$158.3 million.
  • Year-over-year, Retained Earnings skyrocketed 100.0% in 2024 and then crashed 2600760.0% in 2025.
  • A 5-year view of Retained Earnings shows it stood at -$194.2 million in 2022, then fell by 13.29% to -$220.0 million in 2023, then fell by 15.66% to -$254.5 million in 2024, then skyrocketed by 100.0% to $10000.0 in 2025, then plummeted by 2441340.0% to -$244.1 million in 2026.
  • Per Business Quant, the three most recent readings for SNWV's Retained Earnings are -$244.1 million (Q1 2026), $10000.0 (Q4 2025), and -$250.4 million (Q3 2025).